Logo image of MHUA

MEIHUA INTL MEDICAL- CLASS A (MHUA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MHUA - KYG5966G1082 - Common Stock

11.88 USD
+0.22 (+1.89%)
Last: 11/28/2025, 3:49:56 PM
12.1 USD
+0.22 (+1.85%)
After Hours: 11/28/2025, 3:49:56 PM
Fundamental Rating

5

Overall MHUA gets a fundamental rating of 5 out of 10. We evaluated MHUA against 188 industry peers in the Health Care Equipment & Supplies industry. MHUA has an excellent financial health rating, but there are some minor concerns on its profitability. MHUA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MHUA was profitable.
MHUA had a positive operating cash flow in the past year.
MHUA had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

MHUA's Return On Assets of 7.34% is amongst the best of the industry. MHUA outperforms 88.83% of its industry peers.
MHUA has a better Return On Equity (8.48%) than 82.45% of its industry peers.
MHUA has a Return On Invested Capital of 7.79%. This is amongst the best in the industry. MHUA outperforms 84.04% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MHUA is below the industry average of 8.71%.
The last Return On Invested Capital (7.79%) for MHUA is above the 3 year average (6.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROIC 7.79%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 10.37%, MHUA belongs to the best of the industry, outperforming 83.51% of the companies in the same industry.
MHUA's Profit Margin has declined in the last couple of years.
MHUA has a Operating Margin of 13.01%. This is amongst the best in the industry. MHUA outperforms 80.85% of its industry peers.
MHUA's Operating Margin has declined in the last couple of years.
MHUA's Gross Margin of 34.04% is on the low side compared to the rest of the industry. MHUA is outperformed by 73.94% of its industry peers.
In the last couple of years the Gross Margin of MHUA has declined.
Industry RankSector Rank
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

MHUA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MHUA has been increased compared to 1 year ago.
Compared to 5 years ago, MHUA has more shares outstanding
MHUA has about the same debt/assets ratio as last year.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 17.94 indicates that MHUA is not in any danger for bankruptcy at the moment.
MHUA's Altman-Z score of 17.94 is amongst the best of the industry. MHUA outperforms 94.68% of its industry peers.
MHUA has a debt to FCF ratio of 3.19. This is a good value and a sign of high solvency as MHUA would need 3.19 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.19, MHUA belongs to the top of the industry, outperforming 83.51% of the companies in the same industry.
MHUA has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
MHUA's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. MHUA outperforms 67.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Altman-Z 17.94
ROIC/WACC1.04
WACC7.48%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

MHUA has a Current Ratio of 5.71. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.71, MHUA belongs to the top of the industry, outperforming 82.98% of the companies in the same industry.
MHUA has a Quick Ratio of 5.66. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA's Quick ratio of 5.66 is amongst the best of the industry. MHUA outperforms 85.11% of its industry peers.
Industry RankSector Rank
Current Ratio 5.71
Quick Ratio 5.66
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

MHUA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.59%.
MHUA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.75% yearly.
The Revenue has decreased by -5.30% in the past year.
Measured over the past years, MHUA shows a small growth in Revenue. The Revenue has been growing by 4.01% on average per year.
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.24, which indicates a rather expensive current valuation of MHUA.
MHUA's Price/Earnings ratio is a bit cheaper when compared to the industry. MHUA is cheaper than 79.79% of the companies in the same industry.
When comparing the Price/Earnings ratio of MHUA to the average of the S&P500 Index (26.31), we can say MHUA is valued inline with the index average.
Industry RankSector Rank
PE 24.24
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MHUA is valued a bit cheaper than 70.21% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MHUA indicates a somewhat cheap valuation: MHUA is cheaper than 68.09% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 185.23
EV/EBITDA 35.14
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield N/A

MEIHUA INTL MEDICAL- CLASS A

NASDAQ:MHUA (11/28/2025, 3:49:56 PM)

After market: 12.1 +0.22 (+1.85%)

11.88

+0.22 (+1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.52%
Inst Owner Change-22.03%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap664.09M
Revenue(TTM)134.89M
Net Income(TTM)13.99M
AnalystsN/A
Price TargetN/A
Short Float %0.47%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.24
Fwd PE N/A
P/S 4.92
P/FCF 185.23
P/OCF 178.58
P/B 4.03
P/tB 4.04
EV/EBITDA 35.14
EPS(TTM)0.49
EY4.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY0.54%
OCF(TTM)0.07
OCFY0.56%
SpS2.41
BVpS2.95
TBVpS2.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.7
Profitability
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROCE 10.64%
ROIC 7.79%
ROICexc 8.54%
ROICexgc 8.57%
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
FCFM 2.66%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexgc growth 3Y-27.75%
ROICexgc growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Debt/EBITDA 0.63
Cap/Depr 24.05%
Cap/Sales 0.1%
Interest Coverage 69.48
Cash Conversion 20.54%
Profit Quality 25.63%
Current Ratio 5.71
Quick Ratio 5.66
Altman-Z 17.94
F-Score5
WACC7.48%
ROIC/WACC1.04
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.66%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%

MEIHUA INTL MEDICAL- CLASS A / MHUA FAQ

Can you provide the ChartMill fundamental rating for MEIHUA INTL MEDICAL- CLASS A?

ChartMill assigns a fundamental rating of 5 / 10 to MHUA.


Can you provide the valuation status for MEIHUA INTL MEDICAL- CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to MEIHUA INTL MEDICAL- CLASS A (MHUA). This can be considered as Overvalued.


What is the profitability of MHUA stock?

MEIHUA INTL MEDICAL- CLASS A (MHUA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of MEIHUA INTL MEDICAL- CLASS A (MHUA) stock?

The Price/Earnings (PE) ratio for MEIHUA INTL MEDICAL- CLASS A (MHUA) is 24.24 and the Price/Book (PB) ratio is 4.03.